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QUESTION AND ANSWER Open Access
Lifestyle factors in preventing mental health
disorders: an interview with Felice Jacka
Felice N. Jacka
Abstract
In this video Q&A, we talk to Associate Professor Felice Jacka about population health approaches to the primary
prevention of mental disorders across the lifespan. These include addressing lifestyle factors, such as diet, smoking
and physical activity. Latest strategies are being developed through epidemiological studies and clinical trial
evidence. Challenges in preventing mental disorders in general and specifically in the workplace are discussed,
together with future directions on promoting well-being.
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Introduction
Associate Professor Felice Jacka is a Principal Research
Fellow at Deakin University, with honorary positions at
the Murdoch Children’s Research Institute, The University
of Melbourne and the Black Dog Institute. She is
President of both the International Society for Nutritional
Psychiatry Research (ISNPR) and the Australian Alliance
for the Prevention of Mental Disorders (APMD). Her on-
going program of research focuses on lifestyle behaviours,
particularly diet, as risk factors for the common mental
disorders, depression and anxiety. She is internationally
recognised as a pioneering researcher in the new dis-
cipline of nutritional psychiatry, leading multiple stud-
ies establishing associations between diet quality and
mental health in adults, adolescents and children from
many countries. She has also developed a theoretical
framework for this research, which has extensive appli-
cations and implications for public health and clinical
practice. Associate Professor Jacka is the recipient of a
number of grants and awards, including funding for
the first randomised controlled trial (RCT) of dietary
improvement as a treatment strategy in major depres-
sion. Her research program comprises a broad range
of observational investigations, as well as the develop-
ment and evaluation of community-based and clinical
interventions. Her goals are to develop effective, best
practice strategies for the universal primary prevention
of the common mental disorders, as well as effective
secondary prevention and treatment strategies for
those affected.
In this interview (Video Q&A: Additional file 1), we
talk to Associate Professor Felice Jacka about how
lifestyle factors, such as diet, smoking and physical
inactivity, can contribute to common mental health
disorders, like depression and anxiety, across different
population groups. We discuss the latest strategies and
investigations that are addressing the issue and the
future prospects associated with prevention of mental
disorders.
Edited transcript
Tell us a bit about yourself and how you became
involved in population health and mental health
I guess it was through quite an unconventional route.
My first degree was in fine art and I was an artist. But I
had always had a very strong interest in mental health
and also a personal awareness of nutrition. When I came
into psychiatry research, I was intrigued to see that there
really was not an evidence base around the links
between nutrition and mental health. That surprised me,
I guess, because we know that nutrition is very import-
ant for many diseases that are comorbid with depression,
such as cardiovascular disease and obesity. That led me
down this path of investigation.
Many of the research findings that we have uncovered
lend themselves to prevention and public health. Also,
as a pragmatist, it always seems intriguing to me that so
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much money is spent on treatment, and almost nothing
spent on prevention. That seems like a very inefficient
use of resources.
Can you describe the population health approach to the
primary prevention of common mental disorders
(depression and anxiety)?
Previously in prevention research, there have been a
number of studies and programs with a very good evi-
dence base that are focussed on what we call “selected
and indicated prevention”. Selected is when you target
people who are at elevated risk for mental disorders and
the term “indicated prevention” refers to when you
target people who already have elevated symptoms. With
a universal approach to prevention, you are really target-
ing everybody. The advantages for that are that you
don’t then need to screen people, which can be very
expensive. You are also not creating barriers for people
who may not want to seek help because of stigma.
We know now that there are many good ways of pre-
venting mental disorders at the population level, right
across the life course. We know, for example, that if you
have behavioural interventions, social and emotional
learning, or programs that target parenting and support
parents, you may be able to mitigate some of the child
abuse and neglect that we know is a really strong risk
factor for mental disorders across the lifespan. Similarly,
in schools one could target bullying, which we also know
is an important risk factor. There are many studies that
suggest that cognitive behavioural therapy programs are
useful for school children, and of course they can be
delivered online now, which is another useful way of
targeting and delivering these interventions. There is a
good evidence base for workplace mental health pro-
grams that aim to increase resilience and reduce stress.
Then, of course, in older age groups, increasing social
connectedness and social support can be useful in pre-
venting mental health problems. So there are many
interventions that we know have a good evidence base
that can be applied at the population level, and that is
what we are focussing on promoting now.
New evidence around the importance of diet and nu-
trition to the genesis and the progression of common
mental disorders, accompanied by what we already know
about physical activity and how important that is in both
preventing and treating mental disorders, such as de-
pression, is also emerging. Thus we can really start to
think about population-based approaches that are inte-
grated with the strategies that have already been imple-
mented for obesity, cardiovascular disease, and a whole
range of other noncommunicable diseases (NCDs) that
we know are co-morbid with depression. In this way we
can increase efficiency and leverage on what is already
being done in that field.
One of the key recommendations is thus to start
measuring mental health outcomes in such population-
level health interventions. Thus we are not just focussed
on metabolic outcomes and associated NCDs but we are
also measuring mental health.
Discuss how an unhealthy diet can worsen mental health
outcomes
What we have seen now, 4 or 5 years after the first
studies on this topic were published, is that there is
definitely a relationship between diet quality and com-
mon mental disorders, and it seems to exist right
across the life course. We started off investigating this
in adults, but since then we have done a lot of work
looking at this question in adolescents, in older people,
and more recently really looking at the influence of
early life nutritional exposures to mental health out-
comes in children.
The evidence seems pretty clear. There is a relation-
ship between nutrition and mental health across the life
course. Of course, understanding how those relation-
ships work is our next task and this is something that
we are starting to focus on now. For example, a lot of
the data at this point are coming from experimental
models, which are investigations in animals that look at
the direct impact of high-fat refined sugar foods, or
“junk foods”, on a whole range of parameters in the
brain that we know are relevant to mental health. The
effects are not just in the brain, but more systemically,
such as inflammation and oxidative stress.
We know that these sorts of foods are very toxic to
the brain as they reduce proteins, such as brain-derived
neurotrophic factor (BDNF), and they impact on synap-
tic plasticity, learning and memory, and also up-regulate
the stress response, immune and oxidative stress
systems. We are also very interested in the role of the
microbiota, particularly the gut microbiota, and how this
mediates environmental exposures, such as diet, and
their relationships to mental health and other health
outcomes. We think that the gut is a really key part of
that pathway.
What are the latest strategies that are being developed
to promote the prevention of mental disorders?
In Australia, there have been two initiatives – one that is
Australian-focussed and one that is more international.
In 2013 in Australia, we initiated the Alliance for the
Prevention of Mental Disorders (APMD). This is aiming
to progress the agenda and the discussion in Australia
about the need to take prevention more seriously so that
more funding and research energy contributes towards
it. Repeated stakeholder surveys have suggested that pre-
vention is of the highest priority for many people. How-
ever, less than 3 % of the research funding goes to
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prevention, and fewer than 3 % of papers in the field are
on prevention.
Given the enormous burden of illness associated par-
ticularly with depression and common mental disorders,
a group of us felt that we really needed to push this for-
ward in 2013. It comprises many of the most senior re-
searchers in Australia who are interested in prevention
and actively working in this area, plus representatives
from many of the non-government organisations and
representative councils. Together, we really want to get
this conversation moving, advocate for more research
funding for the field, increase capacity in the area, and
get more people talking about this.
More widely, in 2013 we launched the International
Society for Nutritional Psychiatry Research (ISNPR).
This currently has about 200 members from right across
the globe and is becoming more and more active. This
society is aiming to increase the amount of research that
is being done in the field, and raise capacity and col-
laborations to have this topic better represented in
psychiatry research and practice. This lends itself to
the population health approach to both prevention
and treatment.
How does the Alliance for the Prevention of Mental
Disorders (APMD) compare with other prevention
initiatives?
There are a number of initiatives in different countries.
Some of them are part of government departments and
they are very well funded. One particular one in the
US really focuses on substance abuse; others in the
European jurisdiction focus on workplace mental
health. There is the European Network for Mental
Health Promotion (ENMHP), which probably is more
closely aligned with what we are trying to do in
Australia.
Our alliance is very new, so one of the key things
we need to focus on in the next 12 months is to look
at funding strategies so that we can increase the cap-
acity for us to act. This may include lobbying, advo-
cacy and administrative support. We would like to
become a focal point whereby we can provide re-
sources to policymakers and local councils who are
wanting to do some prevention and promotion work.
We want to become the port of call to support and
promote these sorts of programs.
The “SMILES” trial on the dietary intervention for adults
with major depression is underway. Can you comment on
when the results are expected and how this will influence
future research?
Since the end of 2009–2010, there has been an exponen-
tial increase in the number of studies that have looked at
the links between diet and mental health, but they are
largely observational in nature. We have had two really
interesting studies in the last 12 months that have sug-
gested the prevention of depression by improving diet.
However, to date there have been no studies that show
whether if you are already depressed and you improve
your diet, this results in an improvement in mood.
We are running the first study to our knowledge that
really tests this empirically. It is a clinical trial where
people are randomised to receive either a quite detailed
dietary counselling and support, or a social support con-
dition. We hope to have the results by the end of 2015
and the study is underway as we speak.
Importantly with this, we are collecting a host of bio-
logical samples from the participants. We want to know
what happens in the body if you change diet and
whether these changes relate, then, to changes in mood.
Stool, blood and saliva samples are being collected, so
we can look at not only things such as nutrient levels,
but also inflammatory and oxidative stress markers, the
microbiota, very importantly, and also cortisol levels.
These may change when there is a change in diet and
then, hopefully, relate to improvements in mental
health.
Describe how diet quality affects the lifespan from early
life to old age
We looked at the very early life question recently in a
very large sample of Norwegians. We had data for more
than 23,000 mothers and their children, participating in
the ongoing Norwegian Mother and Child Cohort Study
(MoBa). We looked at what mums ate when they were
pregnant and also what children ate in the first few years
of life, and then the children’s mental health outcomes.
Thus internalising and externalising behaviours over the
years to 5 years of age were determined. We saw very
clear relationships between both mothers’ diets and the
children’s diets and the internalising and externalising
behaviours.
There has been more work done in this field since
then. The Generation R cohort study showed quite a
similar set of findings. Then of course we have also done
quite a bit of work in adolescents and showed both
cross-sectionally and prospectively that diet is associated
with depression in adolescence. Given that common
mental disorders have a very early age of onset, we think
that this is highly relevant. We were able to take into ac-
count things such as family functioning and poor family
management as these may influence the relationship. In
the last 4 or 5 years, we have seen these associations
right across countries, across cultures and across age
groups. Thus we are very comfortable in saying that that
relationship does exist. We now need to understand the
mechanism of this association so we can target our
interventions.
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What are the current research approaches to address
other lifestyle factors, such as smoking and physical
activity, on mental disorders?
It is very interesting to consider, over the past 2 years,
the research around smoking cessation. This is because
people with mental disorders are far more likely to
smoke than people without mental disorders. I think in
clinical care there has been this assumption that encour-
aging people to give up smoking will actually add to
their stress levels or maybe worsen their mental health
symptoms as they withdraw from tobacco. However, a
large systematic review has recently showed that people
who give up smoking experience an improvement in
mental health and well-being. Smoking, in people with
mental disorders, is associated with an increased likeli-
hood of suicide, of worse treatment outcomes and a
poorer prognosis. Thus we think that it is very important
that smoking cessation is targeted as a key clinical aspect
of care.
Similarly, physical activity, we have known for quite a
long time now, is important, particularly in the risk for
depression. People who are physically inactive are at
increased risk of depression, whereas people who are
physically active are protected and have a reduced risk.
Exercise is also a very useful treatment strategy in de-
pression. However, to my knowledge – certainly in
Australia – those key understandings have not yet made
their way into official clinical guidelines for treatment of
mental disorders. I think it is very important, not just
from a primary prevention point of view, but from sec-
ondary and tertiary prevention, that diet, physical activ-
ity and smoking are all targeted as key aspects of health
for people with mental disorders, as well as those who
are at risk for physical disorders.
Describe the challenges in preventing mental disorders in
general and in the workplace
Prevention is a really difficult topic for many reasons.
One, of course, relates to policymakers and politicians,
and the second relates to funding bodies in research.
The costs for prevention are incurred up-front but the
payoff is quite a long way down the track. This means it
is less appealing in terms of getting re-elected, etc. This
is a particular challenge but, of course, even though gov-
ernments change in the short term, government bodies,
councils and people are still going to be around in 10 or
15 years’ time. So whilst it is important to be able to
show short-term benefits, there is still a real importance
to be placed on long-term outcomes and there needs to
be a policy framework for long-term outcomes in
prevention.
Similarly, in the workplace, time and costs are issues
for businesses. However, mental disorders account for
quite a large percentage of the burden of sickness
absence, lost productivity, etc. We know that many of
these interventions in the workplace, aiming to improve
depression, are both effective and cost-effective. So there
is an enormous amount to be gained for businesses by
focussing on this and implementing some of these
evidence-based prevention programs in the workplace.
What do you think are the future directions of preventing
mental disorders and promoting well-being?
In Australia, we think it is time for a national strategy
for the prevention of mental disorders. This is some-
thing we are strongly advocating. It is also critical that
policymakers start to fund things that have an evidence
base, and not continually fund research that does not
have an evidence base. I think that is a common issue
across countries.
We are hoping to soon be able to model the short-,
medium- and long-term cost effectiveness of preventa-
tive interventions, similar to what the Department of
Health presented in the Knapp report, Mental health
promotion and prevention: The economic case [1]. This is
one of the things that I think may make a difference. If
you can show how much money, potentially, can be
saved in the long term, as well as the short and medium
term, I think that that strengthens the argument for pre-
vention. It is also really important to focus on the cost
of not doing it. Thus to show that not addressing these
things results in short-, medium- and long-term costs.
That is really quite a potent message as well. We also
need to communicate this to the public because if they
understand that it is possible to prevent mental disor-
ders, they are more likely then to support government
initiatives, even if the payoff is in the long term.
I think it is important that we take a life course ap-
proach to resilience. One of the challenges is that so
many of the environmental factors that impinge on the
risks for mental disorders happen outside of the mental
health sector. Thus it really does need a whole popula-
tion approach. We need to protect people from vulner-
ability risk factors, such as child abuse and neglect,
poverty, bullying, workplace stress, and social isolation,
and target these by building resilience through educa-
tion, social and emotional learning, and community-
based interventions. Volunteering is a really effective
way of building social connectedness. Improving phys-
ical health and health behaviours, such as diet, physical
activity and smoking, is really important.
There are many prevention options that we know have
a good evidence base and that can be implemented right
across the life course. These include parenting, early life,
in the school system, outside in the community and in
older age. We really need to be thinking locally and act-
ing at the community level, but having a framework that
is set at the national level.
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None of these things are impossible, but we do need
political will and we need the community to get behind
that. We would hope that in the future, this life course
approach, this whole strategy for prevention and mental
health promotion – at every stage of life and in every
setting – is developed and taken seriously.
Where can I find out more?
See references [1–10].
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Additional file 1: Audiovisual file - interview with A/Prof Felice N
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